- Custom Synthesis PTC-028 cas 1782970-28-8
Price:
Negotiable
MOQ:
1g
Delivery Time:
Negotiable
Brand:
Crene
Product Description
Chemical Information
| Product name:PTC-028 | Purity:99% min |
| CAS NO:1782970-28-8 | Solubility:DMSO : 125 mg/mL (308.40 mM) |
| Molecular Formula:C19H12F5N5 | Package:Package according to customer requirements |
| Molecular Weight:405.332 | Storage:-20℃ |
Remarks
PTC-028 is an orally bioavailable compound that decreases BMI-1 levels by posttranslational modification. In vivo, orally administered PTC-028, as a single agent, exhibits significant antitumor activity comparable with the standard cisplatin/paclitaxel therapy in an orthotopic mouse model of ovarian cancer.
Synonyms:
6-(5,6-Difluoro-2-methyl-1H-benzimidazol-1-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrazinamine;
2-Pyrazinamine, 6-(5,6-difluoro-2-methyl-1H-benzimidazol-1-yl)-N-[4-(trifluoromethyl)phenyl]-;
BMI-1 Inhibitors Related Products:
PTC-209
Similar Products
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.
Company
Taizhou Crene Biotechnology Co., Ltd.
Location
Add: Economic Developed Zone of Taizhou Zhejiang China.